Ee Hong Tan

2.5k total citations · 1 hit paper
25 papers, 1.9k citations indexed

About

Ee Hong Tan is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Ee Hong Tan has authored 25 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Ee Hong Tan's work include Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). Ee Hong Tan is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). Ee Hong Tan collaborates with scholars based in United Kingdom, Singapore and United States. Ee Hong Tan's co-authors include Owen J. Sansom, Karen H. Vousden, Patricia Müller, Joan S. Brugge, Natalia Lukashchuk, Robert L. Ludwig, David A. Gillespie, Marcin Iwanicki, Saadia A. Karim and Patrick T. Caswell and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Ee Hong Tan

25 papers receiving 1.8k citations

Hit Papers

Mutant p53 Drives Invasion by Promoting Integrin Recycling 2009 2026 2014 2020 2009 200 400 600

Peers

Ee Hong Tan
Ee Hong Tan
Citations per year, relative to Ee Hong Tan Ee Hong Tan (= 1×) peers Ana Cerezo

Countries citing papers authored by Ee Hong Tan

Since Specialization
Citations

This map shows the geographic impact of Ee Hong Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ee Hong Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ee Hong Tan more than expected).

Fields of papers citing papers by Ee Hong Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ee Hong Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ee Hong Tan. The network helps show where Ee Hong Tan may publish in the future.

Co-authorship network of co-authors of Ee Hong Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Ee Hong Tan. A scholar is included among the top collaborators of Ee Hong Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ee Hong Tan. Ee Hong Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goh, Chee Leok, et al.. (2025). Second Victim Syndrome Among Healthcare Professionals: A Systematic Review of Interventions and Outcomes. Journal of Healthcare Leadership. Volume 17. 225–239. 2 indexed citations
2.
Adam, Catherine, Thomas L. Bray, Ana M. Pérez‐López, et al.. (2022). A 5-FU Precursor Designed to Evade Anabolic and Catabolic Drug Pathways and Activated by Pd Chemistry In Vitro and In Vivo. Journal of Medicinal Chemistry. 65(1). 552–561. 31 indexed citations
3.
Venugopal, Vidhya, PK Latha, Ee Hong Tan, et al.. (2020). Heat Stress and Thermal Perceptions Amongst Healthcare Workers During the COVID-19 Pandemic in Developed and Developing Countries. SSRN Electronic Journal. 8 indexed citations
4.
Loveridge, Carolyn J., Ernest Mui, Rachana Patel, et al.. (2017). Increased T-cell Infiltration Elicited by Erk5 Deletion in a Pten -Deficient Mouse Model of Prostate Carcinogenesis. Cancer Research. 77(12). 3158–3168. 15 indexed citations
5.
Loveridge, Carolyn J., Rob vanʼt Hof, Ayala King, et al.. (2017). Analysis of Nkx3.1:Cre-driven Erk5 deletion reveals a profound spinal deformity which is linked to increased osteoclast activity. Scientific Reports. 7(1). 13241–13241. 11 indexed citations
6.
Elbediwy, Ahmed, Zoé I. Vincent‐Mistiaen, Bradley Spencer‐Dene, et al.. (2016). Integrin signalling regulates YAP/TAZ to control skin homeostasis. Development. 143(10). 1674–87. 235 indexed citations
7.
Ahmad, Imran, Ernest Mui, Laura C.A. Galbraith, et al.. (2016). Sleeping Beautyscreen revealsPpargactivation in metastatic prostate cancer. Proceedings of the National Academy of Sciences. 113(29). 8290–8295. 87 indexed citations
8.
Tan, Ee Hong, Jennifer P. Morton, Paul Timpson, et al.. (2013). Functions of TAp63 and p53 in restraining the development of metastatic cancer. Oncogene. 33(25). 3325–3333. 28 indexed citations
9.
Tan, Ee Hong, Benedict Yan, J. Manikandan, et al.. (2012). Gelsolin Induces Colorectal Tumor Cell Invasion via Modulation of the Urokinase-Type Plasminogen Activator Cascade. PLoS ONE. 7(8). e43594–e43594. 65 indexed citations
10.
Müller, Patricia, Patrick T. Caswell, Brendan Doyle, et al.. (2009). Mutant p53 Drives Invasion by Promoting Integrin Recycling. Cell. 139(7). 1327–1341. 641 indexed citations breakdown →
11.
Tan, Ee Hong, Ravi Salgia, B. Besse, et al.. (2009). ABT-869 in non-small cell lung cancer (NSCLC): Interim results. Journal of Clinical Oncology. 27(15_suppl). 8074–8074. 4 indexed citations
12.
Delmar, Paul, Ee Hong Tan, A Płużańska, et al.. (2008). MERIT: Analysis of differential gene expression in patients (pts) with advanced non-small-cell lung cancer (NSCLC) treated with erlotinib. Journal of Clinical Oncology. 26(15_suppl). 8046–8046. 1 indexed citations
13.
Tan, Ee Hong, et al.. (2007). C/EBPα knock-in hepatocytes exhibit increased albumin secretion and urea production. Cell and Tissue Research. 330(3). 427–435. 12 indexed citations
14.
Tan, Ee Hong, Shing Chuan Hooi, Mirtha Laban, et al.. (2005). CCAAT/Enhancer Binding Protein α Knock-in Mice Exhibit Early Liver Glycogen Storage and Reduced Susceptibility to Hepatocellular Carcinoma. Cancer Research. 65(22). 10330–10337. 171 indexed citations
15.
Shepherd, Frances A., José Rodrigues Pereira, Tudor–Eliade Ciuleanu, et al.. (2004). A randomized placebo-controlled trial of erlotinib in patients with advanced non-small cell lung cancer (NSCLC) following failure of 1st line or 2nd line chemotherapy. A National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) trial. Journal of Clinical Oncology. 22(14_suppl). 7022–7022. 212 indexed citations
16.
Bennouna, Jaafar, Ee Hong Tan, Mary O’Brien, et al.. (2004). Phase II study of IV Vinflunine (VFL) as second line treatment of patients (pts) with advanced non-small-cell lung cancer (NSCLC) previously treated with a platinum based regimen. Final results. Journal of Clinical Oncology. 22(14_suppl). 7139–7139. 4 indexed citations
17.
Tan, Ee Hong, et al.. (1998). Mitomycin, ifosfamide and cisplatin in advanced non-small cell lung cancer.. PubMed. 39(8). 357–8. 1 indexed citations
18.
Au, Elizabeth H., et al.. (1996). A Phase II Trial of Etoposide, Leucovorin and 5-Fluorouracil (ELF) in Patients with Advanced Gastric Cancer. Journal of Chemotherapy. 8(4). 300–303. 3 indexed citations
19.
Chew, S K, et al.. (1995). Oral acyclovir in the treatment of adult varicella.. PubMed. 24(2). 316–21. 2 indexed citations
20.
Lamberte, Mario B., et al.. (1992). Philippine External Finance, Domestic Resource Mobilization and Development in the 1970s and 1980s. Medical Entomology and Zoology. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026